
Your diagnosis is the start of a plan, not the end of options
Fatigue, fear, side effects, conflicting advice. If you are looking for more ways to support your treatment safely, start with a conversation and a plan built on your own results.
The concerns we hear from patients

Treatment fatigue
Exhaustion that sleep does not fix, during or after chemotherapy.

Fear of side effects
Worry about what the next cycle will do to your body.

Loss of appetite and weight
Meals become a struggle and strength slips away.

Weakened immunity
Frequent infections and delayed treatment cycles.

Anxiety and sleepless nights
A mind that will not switch off, and a family that feels it too.

Fear of recurrence
Finishing treatment and wondering what to do to stay well.

"No more options"
Being told treatment has run its course, and not being ready to accept it.

Information overload
Conflicting advice online and from well-meaning relatives.

Is integrative care right for me?
Answer eight short questions about your diagnosis, treatment and how you are feeling. We will suggest the starting point that fits you best.
What the evidence and our experience say
Myth
Integrative care means stopping chemotherapy
Our protocols are designed to run alongside conventional treatment, and we coordinate with your oncologist.
Fact
It is personalised, not one-size-fits-all
Therapies, doses and timing are chosen from your diagnostics, cancer type and treatment schedule.
Myth
"Just push through the side effects"
Fatigue, poor appetite and low mood affect how well you tolerate treatment. They deserve proper attention.
Fact
Emotional health is part of treatment
Chronic stress affects immune function. Psychological support is built into every Cellaax plan.
A plan built on real data about your body

Step 1 · Test
Precision diagnostics
Immune, metabolic, tumour and microbiome markers give you and your doctor a factual starting point.

Step 2 · Talk
Doctor-led consultation
Your integrative doctor explains the results and how they relate to your symptoms and treatment.

Step 3 · Treat
Your personalised protocol
A programme across the 7 principles, adjusted as your body responds.
The same principles, applied to your cancer
Every cancer shares vulnerabilities: glucose dependence, immune evasion, toxic load, microbiome disruption and emotional burden. What changes is the emphasis. Select a cancer type to see our approach.
High-Prevalence Cancers
The most commonly treated cancers at Cellaax
Breast Cancer
Understanding it. Breast cancer is the most common cancer among women worldwide. It includes several biologically distinct subtypes: hormone receptor-positive (ER+/PR+), HER2-positive and triple-negative. Each has different growth drivers, treatment sensitivities and supportive care priorities. Most breast cancers are driven at least partly by oestrogen signalling, so hormonal and metabolic factors are especially important in recovery.
Our integrative approach. Cellaax's breast cancer programme starts with a Precision Molecular Approach. Blood-based testing profiles your tumour's biology, including therapy sensitivity testing that shows which natural extracts your cancer cells respond to in the laboratory. These results guide your supplement plan and two personalised options: a gene silencing approach directed at the genes your cancer cells depend on, and an antigen-targeted approach that helps your immune system recognise markers specific to your cancer. Hormone balance is a key focus, with therapeutic nutrition and detoxification therapies supporting how your body processes and clears oestrogen. Our nutrition protocol is meant to support hormone balance. Thermal energy therapies, bio-immunotherapy and biological IV therapies are combined to support immune function throughout treatment. For triple-negative breast cancer, the most aggressive subtype, our metabolic and oxygen therapies are emphasised, as these tumours rely heavily on rapid energy metabolism. Every plan is designed to complement the care you receive from your oncologist.
Lung Cancer
Understanding it. Lung cancer causes more cancer deaths worldwide than any other cancer. It falls into two main groups: non-small cell lung cancer (NSCLC), which includes adenocarcinoma, squamous cell and large cell types, and small cell lung cancer (SCLC), which tends to grow and spread faster. Because the lungs supply oxygen to the whole body, lung cancer can reduce the oxygen your tissues receive at the very time they need it to recover. Tumours themselves often develop in low-oxygen conditions, which is linked to more aggressive growth and reduced treatment response.
Our integrative approach. Cellaax's lung cancer programme starts with a Precision Molecular Approach. Blood-based testing profiles your tumour's biology. This includes therapy sensitivity testing that shows which natural extracts your cancer cells respond to in the laboratory. These results guide your supplement plan and two personalised options: a gene silencing approach directed at the genes your cancer cells depend on, and an antigen-targeted approach that helps your immune system recognise markers specific to your cancer. Oxygen therapies are a central part of the programme and support oxygen delivery to your tissues. Our bio-immunotherapy options include natural killer (NK) cell and dendritic cell (DC) therapies, which work with your own immune cells to support recognition of cancer cells. Biological IV therapies, including high-dose vitamin C, are used to support immune function alongside your conventional treatment. Detoxification therapies are especially relevant for patients with a smoking history or long-term exposure to pollutants. Therapeutic nutrition focuses on anti-inflammatory, antioxidant-rich foods, with targeted supplements to address the nutrient losses common during lung cancer treatment. Every plan is designed to complement the care you receive from your oncologist.
Colorectal Cancer
Understanding it. Colorectal cancer (cancer of the colon and rectum) is strongly linked to dietary patterns, gut microbiome composition, and lifestyle factors — making it one of the cancers most directly amenable to integrative approaches that address these root-cause factors. The gut-immune connection is particularly central here: approximately 70% of the immune system's tissue is located in and around the gastrointestinal tract, and colorectal cancer profoundly disrupts both the microbiome and local immune function.
Our integrative approach. Microbiome restoration is a cornerstone of Cellaax's colorectal cancer programme. Comprehensive stool metagenomics guides a targeted probiotic and prebiotic protocol that works to restore a diverse, cancer-suppressive gut microbiome. Coffee enema protocols support hepatic detoxification and colonic health. Nutritional therapy emphasises a high-fibre, plant-rich diet rich in resistant starch and fermented foods that feed beneficial bacteria, with strict elimination of processed meat, sugar, and refined carbohydrates — all strongly implicated in colorectal cancer promotion. Enzyme therapy addresses digestive insufficiency that often contributes to colorectal cancer presentations. Vitamin B-17 (amygdalin) and metabolic therapies are integrated for their specific activity in gastrointestinal tumour biology. Thermal and oxygenation therapies complete the protocol.
Prostate Cancer
Understanding it. Prostate cancer is the most common cancer in men, spanning a wide spectrum from slow-growing, indolent tumours that may require only active surveillance to aggressive, metastatic disease. The majority of prostate cancers are driven by androgen (testosterone/DHT) signalling — making hormonal balance, metabolic factors (insulin and IGF-1 are major growth signals), and dietary choices critically important. Zinc deficiency is a documented risk factor, as prostate tissue normally maintains the highest zinc concentration of any tissue in the male body.
Our integrative approach. Cellaax's prostate cancer programme emphasises hormonal and metabolic regulation — using a low-glycaemic, anti-inflammatory dietary protocol with specific emphasis on lycopene-rich foods (tomatoes, watermelon — the strongest dietary association with reduced prostate cancer risk), cruciferous vegetables, pomegranate, and green tea, alongside zinc repletion. Our ketogenic metabolic therapy protocol addresses the strong insulin/IGF-1 component of prostate cancer growth. Selenium and Vitamin D IV supplementation addresses the specific micronutrient deficiencies most associated with aggressive prostate cancer. Thermal hyperthermia is used for its documented activity in androgen-sensitive tumour biology. For patients on androgen deprivation therapy, our programme specifically addresses the bone health, cardiovascular, and metabolic consequences of ADT — supporting quality of life through and beyond this treatment phase.
Liver Cancer (Hepatocellular Carcinoma)
Understanding it. Hepatocellular carcinoma (HCC) — primary liver cancer — most commonly arises in the context of chronic liver disease: hepatitis B or C infection, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and chronic alcohol exposure. The liver's central role in detoxification, metabolism, immune function, and protein synthesis means that liver cancer creates a compounding burden on virtually every system of the body — and that addressing toxin accumulation and liver function is a prerequisite for effective recovery.
Our integrative approach. Liver cancer recovery at Cellaax begins with careful hepatic support — using glutathione IV, alpha-lipoic acid, milk thistle (silymarin), and other hepatoprotective agents to support and restore liver cell function. Detoxification therapies are carefully calibrated to support rather than overwhelm a compromised liver. Our anti-microbial protocols specifically address hepatitis virus burden where relevant, including mistletoe extract and ozone therapy for their antiviral properties. Nutritional therapy is essential: a strict anti-inflammatory, plant-rich dietary protocol eliminates the liver burden of processed foods, alcohol, and hepatotoxic substances, while specific functional foods support hepatic regeneration. Coffee enema protocols are adapted carefully for liver cancer patients, supporting bile flow and hepatic detoxification. Thermal and immunotherapy elements are integrated based on individual liver function assessment.
Stomach (Gastric) Cancer
Understanding it. Stomach cancer is one of the most common cancers in Southeast and East Asia. Most cases are linked to long-term infection with Helicobacter pylori (H. pylori), a bacterium that causes ongoing inflammation of the stomach lining. Over many years, this inflammation can damage the lining and lead to cancerous changes. Because the stomach plays a key role in digestion and absorbing nutrients, people with stomach cancer often become undernourished, which weakens the immune system and slows recovery.
Our integrative approach. Eating and absorbing nutrients is often the hardest part of living with stomach cancer, so Cellaax's gastric cancer programme begins by protecting your nutrition. Biological IV therapies deliver key nutrients directly into the bloodstream, bypassing the stomach, with particular attention to vitamin B12, iron and zinc, which are commonly depleted. Our anti-microbial protocols use botanical extracts such as berberine to address H. pylori, alongside the eradication treatment prescribed by your doctor. Oxygen therapies and probiotic support help restore a healthier gut environment and support healing of the stomach lining. A precision blood test examines your tumour's biology and identifies which natural extracts your cancer cells are sensitive to in the laboratory, which informs your supplement plan, gene silencing approach and antigen-targeted approach. NK and dendritic cell therapies add further immune support. Meals are planned around your digestion: smaller portions, digestive enzyme support and gentle, nourishing foods. Every therapy is coordinated with your oncology and gastroenterology team.
Blood & Lymphatic Cancers
Leukaemia, lymphoma, and myeloma presentations
Leukaemia
Understanding it. Leukaemia is a cancer of the blood and bone marrow. Abnormal blood cells multiply out of control and crowd out the healthy red cells, white cells and platelets your body needs. There are four main types: acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML). Each behaves differently, but all disrupt normal blood cell production and weaken the immune system over time.
Our integrative approach. In leukaemia, the cancer cells circulate in the bloodstream itself, so a blood sample gives a direct view of their biology. Cellaax's leukaemia programme is built around this. Molecular testing identifies the genes your leukaemic cells depend on to grow and survive, and our gene silencing approach is then designed to target those specific genes, giving you a plan matched to your own disease rather than to the leukaemia type alone. The same test shows which natural extracts your leukaemic cells respond to in the laboratory, guiding a personalised supplement plan. Because leukaemia arises in the system that produces immune cells, immune support needs careful calibration: NK and dendritic cell therapies and our antigen approach are used selectively and planned with your haematologist. Biological IV therapies, including high-dose vitamin C, support your overall wellbeing during treatment. Therapeutic nutrition focuses on foods and micronutrients that support healthy blood cell production, including iron, vitamin B12, folate and copper. Every element is coordinated with your haematology team.
Lymphoma (Hodgkin's & Non-Hodgkin's)
Understanding it. Lymphoma is a cancer of the lymphatic system, the network of lymph nodes, vessels and organs such as the spleen and thymus that carries and houses much of the immune system. Hodgkin's lymphoma is identified by distinctive cells called Reed-Sternberg cells and generally responds well to conventional treatment. Non-Hodgkin's lymphoma covers more than 60 subtypes, from slow-growing follicular lymphoma to fast-growing diffuse large B-cell lymphoma (DLBCL). Some subtypes are linked to viral infections, particularly Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8).
Our integrative approach. Several lymphoma subtypes have a viral link, so Cellaax's lymphoma programme addresses infection alongside the cancer itself. Our anti-viral protocols and oxygen therapies support the body in managing viruses such as EBV. Gene silencing is a core part of the plan. Lymphoma subtypes differ widely in the genes that drive them, so molecular profiling from a blood sample identifies the genes your lymphoma depends on, and our gene silencing approach is designed around those targets. The same profiling shows which natural extracts your lymphoma cells respond to in the laboratory, which shapes your supplement plan, and informs our antigen-targeted approach. Since lymphoma affects the immune system directly, NK and dendritic cell therapies are used to support healthy immune activity. Biological IV therapies, including mistletoe, support your wellbeing during treatment. A low-glycaemic, anti-inflammatory diet helps reduce the ongoing inflammation common in lymphoma. All therapies are planned together with your haematologist or oncologist.
Multiple Myeloma
Understanding it. Multiple myeloma is a cancer of plasma cells, the white blood cells that produce antibodies. The abnormal plasma cells build up in the bone marrow and crowd out healthy blood cell production. Common effects include bone pain and bone damage, anaemia, high blood calcium, reduced kidney function and frequent infections, as the body makes fewer working antibodies. Myeloma currently has no cure, but many people live with it for years, so long-term disease control and quality of life are central to care.
Our integrative approach. Myeloma is often a long-term condition, so Cellaax's myeloma programme focuses on helping you stay strong over years of treatment, starting with your bones. Vitamin D and vitamin K2 support bone health and calcium balance, dosed according to your blood calcium and kidney results. Biological IV therapies, including curcumin and high-dose vitamin C, support your wellbeing alongside your conventional treatment. A precision blood test profiles your myeloma cells and shows which natural extracts they respond to in the laboratory, which guides your supplement plan. The same results shape our gene silencing approach, directed at the genes your myeloma relies on, and our antigen approach, which helps your immune system recognise your myeloma's specific markers. Because myeloma weakens antibody production and leaves you prone to infection, NK and dendritic cell therapies support your immune defences. A low-sugar, anti-inflammatory diet supports your metabolic health. All therapies are planned with your haematologist.
Digestive System Cancers
Pancreatic, oesophageal, gallbladder, and small intestine
Pancreatic Cancer
Understanding it. Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is one of the hardest cancers to treat. It is often found late, frequently resists standard chemotherapy, and is surrounded by dense scar-like tissue that makes it difficult for immune cells and medicines to reach the tumour. The pancreas also makes digestive enzymes and insulin, so pancreatic cancer often disrupts both. This can cause poor digestion, weight loss and unstable blood sugar, all of which make recovery harder.
Our integrative approach. Pancreatic cancer affects both digestion and blood sugar, so Cellaax's pancreatic cancer programme begins with these two areas. Digestive enzyme replacement helps your body break down and absorb food, supporting your weight and strength. Our metabolic therapies use a carefully supervised low-carbohydrate approach to help stabilise blood sugar. This is adjusted for your weight and nutritional needs, since many pancreatic cancer patients struggle to keep weight on. Because this cancer often resists standard treatment, personalisation matters even more. A precision blood test profiles your tumour cells and shows which natural extracts they respond to in the laboratory, guiding your supplement plan, our gene silencing approach and our antigen-targeted approach. NK and dendritic cell therapies add immune support. Thermal energy therapies, oxygen therapies and biological IV therapies, including high-dose vitamin C and glutathione, support you through treatment, with detoxification therapies supporting liver function. Every therapy is coordinated with your oncologist.
Oesophageal Cancer
Understanding it. Oesophageal cancer has two main types. Squamous cell carcinoma is more common in Asia and is linked to smoking, alcohol and very hot drinks. Adenocarcinoma develops from Barrett's oesophagus, a change in the lining of the oesophagus caused by long-term acid reflux. Both types often make swallowing difficult, which reduces how much a person can eat and leads to weight loss and malnutrition. This weakens the immune system and makes recovery harder.
Our integrative approach. When swallowing becomes difficult, every meal can feel like a struggle, so Cellaax's oesophageal cancer programme makes sure you are nourished whatever your swallowing ability. Biological IV therapies deliver vitamins, minerals and amino acids straight into the bloodstream, without relying on eating. Therapeutic nutrition is adapted to what you can comfortably swallow, using smoothies, soups and blended meals rich in plant nutrients. For patients with reflux, probiotics, anti-inflammatory foods and supplements such as zinc carnosine and DGL liquorice help support the lining of the oesophagus. Alongside this, a precision blood test profiles your tumour cells and shows which natural extracts they respond to in the laboratory. These results guide your supplement plan, our gene silencing approach and our antigen-targeted approach. NK and dendritic cell therapies and bio-immunotherapy support your immune defences during treatment. Every therapy is planned alongside your oncologist and surgical team.
Gallbladder & Bile Duct Cancer
Understanding it. Gallbladder cancer and bile duct cancer (cholangiocarcinoma) start in the biliary system, the organs and ducts that make, store and carry bile. Bile is the digestive fluid the body needs to digest fat and absorb vitamins A, D, E and K. Bile duct cancer can develop inside the liver (intrahepatic), where the ducts leave the liver (perihilar), or closer to the intestine (distal). Both cancers are linked to long-term inflammation of the biliary tract, gallstones, toxin exposure and liver fluke infection, which is common in parts of Southeast Asia. They often disrupt digestion and liver function.
Our integrative approach. The liver and bile ducts work as one system, so Cellaax's biliary cancer programme centres on supporting liver function. Detoxification therapies and biological IV therapies, including glutathione and alpha-lipoic acid, alongside milk thistle, help support the liver while bile flow is affected. Where liver fluke infection is identified, our anti-microbial protocols use botanical extracts alongside the anti-parasitic treatment prescribed by your doctor. Because blocked bile flow limits fat absorption, vitamins A, D, E and K are given by IV or injection where needed, and the diet temporarily lowers fat while including bile-supporting foods such as bitter greens, artichoke and radish. A precision blood test profiles your tumour cells and shows which natural extracts they respond to in the laboratory. These results guide your supplement plan, our gene silencing approach and our antigen-targeted approach. NK and dendritic cell therapies support your immune system throughout. Every therapy is coordinated with your oncologist and hepatobiliary team.
Urological & Gynaecological Cancers
Kidney, bladder, cervical, ovarian, uterine, and related
Ovarian Cancer
Understanding it. Ovarian cancer is the most lethal gynaecological cancer, largely because it is often diagnosed at an advanced stage — when it has spread beyond the ovaries into the peritoneal cavity. The most common subtype is high-grade serous ovarian carcinoma, which is aggressive and prone to recurrence despite initial chemotherapy response. Oestrogen, inflammation, and oxidative stress play central roles in ovarian cancer promotion.
Our integrative approach. Cellaax's ovarian cancer programme addresses hormonal balance, detoxification, and immune restoration as its primary pillars. Oestrogen metabolism support — through dietary indole-3-carbinol, diindolylmethane (DIM), and specific detoxification support — helps modulate the hormonal environment. Our Full Body Hyperthermia protocol is used specifically for its peritoneal distribution of thermal effect — the same rationale as hyperthermic intraperitoneal chemotherapy (HIPEC) used conventionally, but delivered through a systemic, non-toxic approach. High-dose Vitamin C IV is used for its well-documented sensitisation of ovarian cancer cells to platinum-based chemotherapy and its direct anti-tumour effects. Bio-immunotherapy targets peritoneal metastatic deposits. Nutritional therapy emphasises quercetin, EGCG, and curcumin — compounds with specific documented activity in ovarian cancer cell lines — delivered both through functional foods and targeted supplementation.
Cervical Cancer
Understanding it. Almost all cervical cancers are caused by long-lasting infection with high-risk types of human papillomavirus (HPV), especially HPV 16 and 18. In most people, the immune system clears HPV on its own. Cancer can develop when the infection persists for years. Factors that make this more likely include smoking, a weakened immune system and low levels of certain nutrients such as folate and vitamins A and C. This is why immune support and anti-viral care are central to an integrative approach.
Our integrative approach. Because cervical cancer begins with a virus the immune system failed to clear, Cellaax's cervical cancer programme focuses on supporting your immune response and addressing HPV. Our anti-viral protocols and oxygen therapies support the body in managing persistent infection. NK and dendritic cell therapies and bio-immunotherapy help strengthen the immune activity that normally keeps HPV in check. Biological IV therapies restore nutrients linked to HPV persistence, including folate, vitamin A, vitamin C and zinc. To personalise your plan, a precision blood test profiles your tumour cells and identifies the genes they rely on to grow and survive. Our gene silencing approach is then designed around those specific genes, so your plan targets your own cancer's biology. The same test shows which natural extracts your cancer cells respond to in the laboratory, guiding your supplement plan, and informs our antigen approach, which helps your immune system recognise markers specific to your cancer. Thermal energy therapies and therapeutic nutrition provide further support throughout treatment. Every therapy is planned alongside your gynaecological oncologist.
Uterine (Endometrial) Cancer
Understanding it. Endometrial (uterine) cancer is the most common gynaecological cancer, and its rising incidence closely mirrors the global rise of obesity and metabolic syndrome. It is predominantly oestrogen-driven — particularly by the oestrogenic effect of adipose tissue, which produces oestrone from androgens via the aromatase enzyme. Insulin resistance and elevated IGF-1 are equally important growth drivers. This makes metabolic normalisation — reducing insulin resistance, improving adipose oestrogen metabolism, and achieving healthy body composition — central to both prevention and recovery.
Our integrative approach. Metabolic therapy is the foundation of Cellaax's endometrial cancer programme. Ketogenic dietary therapy, therapeutic fasting, and intensive blood sugar regulation work together to reduce the insulin and IGF-1 signalling that drives endometrial proliferation. Oestrogen metabolism support — DIM, I3C, and specific detoxification support through sulphur metabolism pathways — is used to shift oestrogen processing toward less proliferative metabolites. Exercise coaching is integrated into the programme, as physical activity has a uniquely strong evidence base for reducing endometrial cancer recurrence risk. Our immunotherapy and hyperthermia protocols address tumour biology directly. Emotional and spiritual support often addresses the significant life-stage and identity dimensions that frequently characterise the endometrial cancer experience in perimenopausal and postmenopausal women.
Kidney (Renal Cell) Cancer
Understanding it. Renal cell carcinoma (RCC) is the most common type of kidney cancer. It stands out because it interacts strongly with the immune system, and it is one of the cancers where immunotherapy has become an established part of conventional treatment. RCC is also linked to obesity, high blood pressure, smoking and exposure to heavy metals such as cadmium and arsenic. This makes metabolic health and detoxification important parts of an integrative approach.
Our integrative approach. Kidney cancer is closely tied to the immune system, so immune support sits at the centre of Cellaax's kidney cancer programme. It starts with a precision blood test that profiles your tumour cells. From this, our tumour antigen approach identifies the antigens, the markers on the surface of your cancer cells, and uses them to help train your immune system to recognise and respond to your cancer specifically. The same profiling identifies the genes your tumour relies on to grow and survive, and our gene silencing approach is designed around those genes, so your plan is based on your own cancer's biology. The test also shows which natural extracts your cancer cells respond to in the laboratory, which shapes your supplement plan. NK and dendritic cell therapies, together with bio-immunotherapy, further support your body's own immune activity. Detoxification therapies, including alpha-lipoic acid IV, address heavy metal exposure, with every protocol adjusted to protect your remaining kidney function. Oxygen therapies provide further support. Blood pressure is managed through diet, nutrition and lifestyle, and therapeutic nutrition focuses on kidney-friendly foods and good hydration. Thermal energy therapies are used with care and monitored closely. Every therapy is coordinated with your oncologist and nephrologist.
Bladder Cancer
Understanding it. Bladder cancer is closely linked to exposure to cancer-causing chemicals. Smoking is the biggest single risk factor. Others include workplace chemicals such as dyes and industrial solvents, and long-term arsenic in drinking water. Because urine is stored in the bladder, any harmful substances it carries stay in contact with the bladder lining for long periods. Early-stage bladder cancer that has not grown into the muscle often comes back after treatment, so preventing recurrence is a major focus of long-term care.
Our integrative approach. Bladder cancer often returns, so Cellaax's bladder cancer programme is built for the long term, with two priorities: reducing toxin exposure and supporting ongoing immune protection. Detoxification therapies, including alpha-lipoic acid and glutathione IV with supportive botanicals, help clear tobacco-related toxins and heavy metals such as arsenic. Good hydration is encouraged throughout, to help flush the bladder and support the kidneys. A precision blood test profiles your tumour cells and guides two personalised options. Our tumour antigen approach identifies the markers on your cancer cells and helps your immune system learn to recognise them. Our gene silencing approach targets the genes your cancer relies on to grow. The same test shows which natural extracts your cancer cells respond to in the laboratory, which shapes a supplement plan that may include green tea extract (EGCG), vitamin D and selenium. NK and dendritic cell therapies and bio-immunotherapy support your immune defences between treatments, and probiotic support helps maintain a healthy microbiome. Every therapy is coordinated with your urologist and oncologist.
Brain & Nervous System Cancers
Glioma, glioblastoma, meningioma, neuroblastoma
Brain Cancer (Glioma / GBM)
Understanding it. Glioblastoma (GBM) is the most aggressive tumour that starts in the brain. It grows quickly, spreads into surrounding brain tissue and usually returns even after surgery and radiotherapy. Lower-grade gliomas (grade II and III) vary more in how they behave but are still difficult to treat. The blood-brain barrier protects the brain from harmful substances but also keeps out many medicines, which makes treatment harder. Because brain tissue has limited ability to repair itself, protecting memory, movement and thinking is as important as controlling the tumour.
Our integrative approach. GBM depends heavily on glucose for energy, so metabolic therapy is a cornerstone of Cellaax's brain tumour programme. A medically supervised ketogenic diet is introduced with regular blood glucose and ketone monitoring, adjusted around your treatment and steroid medication. A precision blood test profiles your tumour cells and shows which natural extracts they respond to in the laboratory, guiding a personalised supplement plan that may include curcumin and melatonin. NK and dendritic cell therapies support your immune defences. Oxygen therapies and biological IV therapies provide further support through treatment. Every therapy is coordinated with your neuro-oncologist and planned around your surgery and radiotherapy.
Head, Neck & Skin Cancers
Thyroid, nasopharyngeal, melanoma, and related
Thyroid Cancer
Understanding it. Thyroid cancer is the most common endocrine malignancy and has been among the fastest-rising cancer types globally, with strong associations with radiation exposure, iodine deficiency, and immune dysfunction. Most thyroid cancers (papillary and follicular) have good prognoses with conventional treatment; anaplastic thyroid cancer is extremely aggressive. The thyroid gland's central role in metabolic regulation means that thyroid cancer has systemic metabolic consequences that integrative care must address.
Our integrative approach. Iodine status assessment and management is central in Cellaax's thyroid cancer programme — while iodine deficiency is a risk factor for differentiated thyroid cancers, excess iodine can drive TSH suppression. Our nutritional assessment guides precise iodine management. Selenium is a critical micronutrient for thyroid enzyme function and is frequently deficient in thyroid cancer patients; selenium IV is integrated. Sea vegetables (in controlled quantities) provide trace minerals supporting thyroid tissue. Detoxification from halide competitors — bromide (from processed bread), fluoride (from tap water), and chloride — is addressed, as these compete with iodine for thyroid uptake. Our bio-immunotherapy programme is used to support immune surveillance for recurrence. For patients on thyroid hormone replacement post-surgery, our protocol addresses the metabolic implications of thyroid hormone management, including optimisation of T3/T4 ratios and adrenal support.
Nasopharyngeal Cancer
Understanding it. Nasopharyngeal carcinoma (NPC) is far more common in Southeast Asia than in most of the world, particularly among people of southern Chinese descent. It is closely linked to Epstein-Barr virus (EBV), inherited susceptibility, and diets high in salted and preserved foods, which contain nitrosamines. Because a virus plays such a clear role, immune support and anti-viral care are especially important in an integrative approach.
Our integrative approach. EBV plays a central role in NPC, so Cellaax's NPC programme combines anti-viral care with precision immune therapies. Our anti-viral protocols and oxygen therapies support the body in keeping EBV in check, with biological IV therapies such as mistletoe and high-dose vitamin C supporting immune function alongside radiotherapy. A precision blood test profiles your tumour cells and guides two personalised options. Our gene silencing approach is designed around the genes your cancer relies on to grow. Our tumour antigen approach identifies markers on your cancer cells and helps your immune system learn to recognise and respond to them. The same test shows which natural extracts your cancer cells respond to in the laboratory, which shapes your supplement plan. NK and dendritic cell therapies add further immune support. Therapeutic nutrition removes salted and preserved foods and focuses on green tea, cruciferous vegetables and other plant-rich foods. For radiotherapy side effects such as dry mouth, mouth sores and hearing changes, we provide supportive care that includes ozonated oil for the mouth and nutrients that support the salivary glands and nerves. Every therapy is coordinated with your oncologist and ENT team.
Melanoma & Skin Cancers
Understanding it. Melanoma is less common than basal cell and squamous cell skin cancers, but it is the most dangerous because it can spread to other organs early. Like kidney cancer, melanoma interacts strongly with the immune system, and it is one of the cancers where conventional immunotherapy has made the biggest advances. Advanced melanoma that has spread to internal organs is serious, but treatment options have improved considerably in recent years.
Our integrative approach. Melanoma responds to the immune system more than most cancers, so Cellaax's melanoma programme puts immune therapies first. NK and dendritic cell therapies, together with bio-immunotherapy, support your body's own immune activity. A precision blood test profiles your tumour cells and guides two personalised options. Our tumour antigen approach identifies the markers on your melanoma cells and helps your immune system learn to recognise them. Our gene silencing approach is designed around the genes your melanoma relies on to grow and spread. The same test shows which natural extracts your cancer cells respond to in the laboratory, guiding a supplement plan that may include quercetin, green tea extract (EGCG) and resveratrol. Vitamin D receives particular attention, as low levels are common in people with melanoma, and your levels are tested and corrected as needed. Thermal energy therapies, biological IV therapies and therapeutic nutrition provide further support. Every therapy is coordinated with your oncologist and dermatologist.
Oral, Tongue & Salivary Gland Cancer
Understanding it. Cancers of the mouth (tongue, lips, inner cheeks, floor of the mouth and hard palate) and the throat just behind it are mostly linked to smoking and alcohol. A growing share of throat cancers are caused by HPV infection, especially HPV 16. Betel nut chewing, common across Southeast and South Asia, is another major risk factor for mouth cancer in our region. Poor oral health and long-term dental infection can also add to inflammation in the mouth.
Our integrative approach. Treatment for mouth cancer affects eating, speaking and swallowing, so Cellaax's oral cancer programme focuses on protecting these functions while supporting your recovery. Care begins with a dental assessment, coordinated with your dentist, to address any infection before radiotherapy and reduce the risk of complications. Where HPV is involved, our anti-viral protocols, oxygen therapies and high-dose vitamin C IV support the body in managing the infection. A precision blood test profiles your tumour cells and guides two personalised options. Our gene silencing approach targets the genes your cancer relies on to grow. Our tumour antigen approach identifies markers on your cancer cells and helps your immune system learn to recognise them. The same test shows which natural extracts your cancer cells respond to in the laboratory, which shapes your supplement plan. NK and dendritic cell therapies add further immune support. Radiotherapy to the head and neck causes significant side effects, so our supportive care addresses mouth sores with ozonated oil, L-glutamine and zinc carnosine, and provides support for dry mouth and taste changes. Liquid and soft-food nutrition plans keep you nourished when eating is difficult. Every therapy is coordinated with your oncologist and head and neck surgical team.
Additional Cancer Types Treated
We build a personalised programme for every presentation, including:
Not sure if your cancer type is listed? Contact us and we will discuss your situation.

Ready to discuss your diagnosis?
Book a free consultation to learn how our approach applies to your cancer type and your goals.
